Putting Cost-Benefit Analysis in its Place: Rethinking Regulatory Review
Putting Cost-Benefit Analysis in its Place: Rethinking Regulatory Review
复制标题
将成本效益分析放在适当的位置：重新思考监管审查
DOI：
--
复制
发表时间：
2010
期刊：
影响因子：
--
通讯作者：
S. Rose
中科院分区：
文献类型：
--
作者：
S. Rose
政策制定者需要重新评估成本效益分析（CBA）在监管审查中的作用。虽然它仍然是一个有价值的工具，一些紧迫的当前问题不适合CBA范式。特别是，气候变化、核事故风险和保护生物多样性可能产生非常长期的影响，可能产生灾难性和不可逆转的影响。本文旨在通过展示成本效益分析的优势和局限性，将其置于适当的位置。奥巴马政府应该重新考虑使用成本效益分析作为评估监管政策的一种方式，并制定程序，将其使用限制在其基本假设符合问题性质的政策领域。
Policymakers need to reassess the role of cost-benefit analysis (CBA) in regulatory review. Although it remains a valuable tool, a number of pressing current problems do not fit well into the CBA paradigm. In particular, climate change, nuclear accident risks, and the preservation of biodiversity can have very long-run impacts that may produce catastrophic and irreversible effects. This article seeks to put cost-benefit analysis in its place by demonstrating both its strengths and its limitations. The Obama Administration should rethink the use of CBA as a way to evaluate regulatory policies and develop procedures to restrict its use to policy areas where its underlying assumptions fit the nature of the problem.